Shazli N. Malik

Statistics

Publications

Citations

1.4K

H-Index

Active since

1999

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

University of Florida

Florida College

Murphy Oil Corporation (United States)

Shazli N. Malik is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and molecular oncology.

Publications per year

1999–2007

Publications

Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer

Jeffrey I. Kreisberg, Shazli N. Malik, Thomas J. Prihoda et al. · Cancer Research · 2004 · 323 citations

Medicine, Oncology, Urology +17

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

Shazli N. Malik, Michael G. Brattain, P. Ghosh et al. · PubMed · 2002 · 322 citations

Medicine, Oncology, Pathology +17

Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.

Abhik Bandyopadhyay, Fernando López‐Casillas, Shazli N. Malik et al. · PubMed · 2002 · 143 citations

Medicine, Oncology, Pharmacology +11

Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation

Roble Bedolla, Thomas J. Prihoda, Jeffrey I. Kreisberg et al. · Clinical Cancer Research · 2007 · 143 citations

Medicine, Oncology, Pathology +17

Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.

Shazli N. Malik, Lillian L. Siu, Eric K. Rowinsky et al. · PubMed · 2003 · 130 citations

Medicine, Oncology, Pharmacology +17

1–5 of 11